Missed opportunities: Injection drug use and HIV/AIDS in Victoria, Canada

International Journal of Drug Policy

Volumn 15, Issue 3, 2004, Pages 171-181

  Stajduhar, Kelli I ^a   Poffenroth, Linda ^b   Wong, Elsie ^c   Archibald, Chris P ^d   Sutherland, Donald ^d   Rekart, Michael ^e  

^a UNIVERSITY OF VICTORIA   (Canada)

^b Health Canada   (Canada)

^c Public Health Microbiology and Reference Laboratory   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

HIV; Injection drug use; Qualitative; Rapid assessment

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANADA; DISEASE TRANSMISSION; DRUG ABUSE; DRUG DEPENDENCE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; PERCEPTION; PRIORITY JOURNAL; REVIEW; SOCIETY;

EID: 2642574847     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2004.01.001     Document Type: Article

References (56)

1. Adler, P. A., & Adler, P. A. (1994). Observational techniques. In N. K. Denzin & Y. S. Lincoln (Eds.), Handbook of qualitative research (pp. 377-392). Thousand Oaks, CA: Sage.
2. Archibald C.P., Ofner M., Strathdee S.A., Patrick D.M., Sutherland D., Rekart M.L., et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17:1998;160-166
3. Baker, et al. (2000). Rapid assessment, response and evaluation - Final report - Philadelphia. Philadelphia, PA: Author.
4. Bernard, R. (1994). Participant observation. In R. Bernard (Ed.), Research methods in anthropology (pp. 136-164). Newbury Park, CA: Sage.
5. Bognar, C. J., Legare, J., & Ross, S. (1998). Injection drug use and the epidemic of HIV in the Lower Mainland. Vancouver, BC: Author.
6. Bottorff, J. L. (1994). Using videotaped recordings in qualitative research. In J. M. Morse (Ed.), Critical issues in qualitative research (pp. 244-261). Newbury Park, CA: Sage.
7. Bourgois P., Bruneau J. Needle exchange, HIV infection, and the politics of science: Confronting Canada's cocaine injection epidemic with participant observation. Medical Anthropology. 18(4):2000;324-350
8. Braunstein M.S. Sampling a hidden population: Noninstitutionalized drug users. AIDS Education and Prevention. 5(2):1993;131-140
9. British Columbia Centre for Disease Control. (1999). HIV/AIDS update - Semi-annual, 1999. Vancouver, British Columbia: BC Centre for Disease Control.
10. British Columbia Ministry of Health. (1999). Vital statistics and health status indicators - Standardized mortality ratio by local health area drug-induced deaths. British Columbia, 1993-1997 and 1998. Victoria, British Columbia: BC Ministry of Health.
11. Canadian Foundation for Drug Policy. (2001). HIV/AIDS and injection drug use: A national action plan - Report of the National Task Force on HIV, AIDS, and Injection Drug Use. Available [On-line]: www.cfdp.ca2001.
12. Capital Health Region. (2000a). Capital Health Region Regional Services Plan. Victoria, BC: Capital Health Region.
13. Capital Health Region (2000b). Victoria Capital Health Region Strategic Plan for HIV/AIDS. Victoria, BC: Capital Health Region.
14. City of Victoria. (2003). Welcome to Victoria - "City of Gardens". Available [On-line]: www.city.victoria.bc.ca.
15. Emerson, R. M., Fretz, R. I., & Shaw, L. L. (1995). Writing ethnographic fieldnotes. Chicago: The University of Chicago Press.
16. Fitch C., Rhodes T., Stimson G.V. Origins of an epidemic: The methodological and political emergence of rapid assessment. International Journal of Drug Policy. 11:2000;63-82
17. Friedman S.R., Jose B., Deren S., Des Jarlais D.C., Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. American Journal of Epidemiology. 142:1995;864-874
18. Fussell, B., et al. (1999). Rapid assessment, response and evaluation - Miami/Dade County. Miami, Florida: Author.
19. Griffiths P., Gossop M., Powis B., Strang J. Reaching hidden populations of drug users by privileged access interviews: Methodological and practical issues. Addiction. 88(12):1993;1617-1626
20. Hagan H., Des Jarlais D.C., Friedman S.R., Purchase D., Alter M.J. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health. 85(11):1995;1531-1537
21. Hagan H., Des Jarlais D.C., Purchase D., Friedman S.R., Reid T.R., Bell T.A. An interview study of participants in the Tacoma Syringe exchange. Addiction. 88:1993;1691-1697
22. Harvey E., Strathdee S.A., Patrick D.M., Ofner M., Archibald C.P., Eades G., et al. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. AIDS Care. 10(3):1998;313-321
23. Health Canada. (1998). The Canadian strategy on HIV/AIDS: Moving forward together. Ottawa, Ontario: Minister of Public Works and Government Services Canada.
24. Health Canada. (1999). HIV/AIDS among injection drug users in Canada. Epi update. Ottawa, Ontario: Minister of Public Works and Government Services Canada.
25. Health Canada. (2000). HIV and AIDS in Canada: Surveillance report to June 30, 2000. Ottawa, Ontario: Minister of Public Works and Government Services Canada.
26. Health Canada. (2002). HIV/AIDS among injection drug users in Canada. Ottawa, Ontario: Minister of Public Works and Government Services Canada.
27. Huberman, A. M., & Miles, M. B. (1994). Data management and data analysis methods. In N. K. Denzin & Y. S. Lincoln (Eds.), Handbook of qualitative research (pp. 428-444). Thousand Oaks, CA: Sage.
28. Jorgensen, D. L. (1989). Participant observation: A methodology for human studies. Newbury Park, CA: Sage.
29. Jurgens, R., Cartledge, V., Kilby, D., & Roy, D. J. (1999). Injection drug use and HIV/AIDS: Legal and ethical issues. Ottawa, Ontario: Canadian HIV/AIDS Legal Network.
30. Kerr, T. (2000). Safe injection facilities: Proposal for a Vancouver pilot project. Vancouver, BC: Harm Reduction Action Society.
31. Kwiatkowski C.F., Fortuin C.K., Booth R.E. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction. 97(1):2002;1289-1294
32. Latkin C., Mandell W., Vlahov D., Oziemkowska M., Celentano C. People and places: Behavioural settings and personal network characteristics as correlates of needle sharing. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 13:1996;273-280
33. Link B.G., Phelan J. Social conditions as fundamental causes of disease. Journal of Health and Social Behavior. 35:1995;80-94
34. Lovell A.M. Risking risk: The influence of types of capital and social networks on the injection practices of drug users. Social Science and Medicine. 55(5):2002;803-821
35. MacPherson, D. (2000). A framework for action: A four pillar approach to drug problems in Vancouver. Vancouver, BC: City of Vancouver.
36. Madray H., van Hulst Y. Reducing HIV/AIDS high-risk behavior among injection drug users: Peers vs. Education. Journal of Drug Education. 30(2):2000;205-211
37. Miller C.L., Tyndall M., Spittal P., Li K., Palepu A., Schechter M.T. Risk-taking behaviors among injection drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. Journal of Urban Health. 79(2):2002;257-265
38. Montgomery S.B., Hyde J., De Rosa C.J., Rohrbach L.A., Ennett S., Harvey S.M., et al. Gender differences in HIV risk behaviors among young injections and their social network members. The American Journal of Drug and Alcohol Abuse. 28(3):2002;453-475
39. Morse, J. (1994). Emerging from the data: The cognitive processes of analysis in qualitative inquiry. In J. Morse (Ed.), Critical issues in qualitative research methods (pp. 23-42). Thousand Oaks, CA: Sage.
40. Morse, J. M., & Field, P. A. (1995). Qualitative research methods for health professionals (2nd ed.). Thousand Oaks, CA: Sage.
41. Neaigus A., Freidman S., Curtis R., Des Jarlais D.C., Furst R.T., Jose B. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Social Science & Medicine. 38(1):1994;67-78
42. Needle, R. H., Trotter, R. T., Goosby, E., Bates, C., & von Zinkernagel, D. (2000a). A guide for conducting community-based rapid assessment, response, and evaluation. Washington, DC: Office of HIV/AIDS Policy, Department of Health and Human Services.
43. Needle R.H., Trotter R.T., Goosby E., Bates C., Von Zinkernagel D. Methodologically sound rapid assessment and response: Providing timely data for policy development on drug use interventions and HIV prevention. International Journal of Drug Policy. 11:2000;19-23
44. Palepu A., Strathdee S.A., Hogg R.S., Anis A.H., Rae S., Cornelisse P.G.A., et al. The social determinants of emergency department and hospital use by injection drug users in Canada. Journal of Urban Health. 76(4):1999;409-418
45. Patrick D.M., Strathdee S.A., Archibald C.P., Ofner M., Craib K.J., Cornelisse P.G., et al. Determinants of HIV seroconversion in injection drug users during a period of risking prevalence in Vancouver. International Journal of AIDS and Sexually Transmitted Diseases. 8:1997;437-445
46. Poffenroth, L., Hanson, L., & Archibald, C. P. (2000). Report of the Victoria 1999 IDU study. Ottawa, Ontario: Health Canada.
47. Rhodes T., Fitch C., Stimson G.V., Kumar M.S. Rapid assessment in the drugs field. International Journal of Drug Policy. 11:2000;1-11
48. Richards, L. (1999). Using NVivo in qualitative research. Victoria, Australia: Qualitative Solutions and Research.
49. Riley E.D., Safaeian M., Strathdee S.A., Marx M.A., Huettner S., Beilenson P., et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 24(1):2000;57-61
50. Sherman S.G., Latkin C.A. Drug users' involvement in the drug economy: Implications for harm reduction and HIV prevention programs. Journal of Urban Health. 79(2):2002;266-277
51. Simpson, H., et al. (2000). Communities combating HIV/AIDS in racial and ethnic minority populations - Detroit, Michigan. Detroit, Michigan: Author.
52. Singer M., Stopka T., Siano C., Springer K., Barton G., Khoshnood K., et al. The social geography of AIDS and hepatitis risk: Qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. American Journal of Public Health. 90(7):2000;1049-1056
53. Strathdee S.A., Patrick D.M., Archibald C.P., Ofner M., Cornelisse P.G., Rekart M., et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction. 92:1997;1339-1348
54. Trotter, R. T., & Needle, R. H. (2000). Crisis response team initiative: RARE project field assessment methods training workbook. Washington, DC: U.S. Department of Health and Human Services Office of HIVAIDS Policy.
55. Trotter R.T., Needle R.H., Goosby E., Bates C., Singer M.A. A methodological model for rapid assessment, response, and evaluation: The RARE program in public health. Field Methods. 13(2):2001;137-159
56. Watters J.K., Estilo M.J., Clark G.L., Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Journal of the American Medical Association. 271:1994;115-120